Health and Healthcare

Merck : MRK

All Merck Articles

1087 Articles

Jon C. Ogg | Jul 9, 2019 at 4:45 PM EDT

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the…

Jon C. Ogg | Jul 3, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Barrick Gold, CannTrust, Foot Locker, Inogen, L3Harris, Merck, Petrobras, Starbucks, Symantec, Tesla and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Barrick Gold, CannTrust, Foot Locker, Inogen, L3Harris, Merck, Petrobras,…

Chris Lange | Jun 26, 2019 at 8:30 AM EDT

Short Sellers Seek Direction on Big Pharma

The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Jun 15, 2019 at 10:35 AM EDT

Our Top 10 Stock Moves & News Items for the Week

Top stock stories for the week of June 14, 2019 from earnings, mergers, analyst calls and more.

Jon C. Ogg | Jun 14, 2019 at 11:45 AM EDT

High Hopes and Expectations for Merck’s First Investor Day in Years

Merck is set to host its Investor Day on June 20. Investors will have a high bar of expectations because…

Chris Lange | Jun 12, 2019 at 8:30 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The May 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 28, 2019 at 8:50 AM EDT

Big Pharma Short Sellers Hike Their Bets

The May 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | May 13, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Alarm.com, Exxon, Goldman Sachs BDC, Merck, Pinterest, Shopify, Wendy’s, Zoom Video and More

The top analyst upgrades, downgrades and initiations seen on Monday included Alarm.com, Exxon Mobil, Goldman Sachs BDC, Merck, Pinterest, Shopify,…

Chris Lange | May 10, 2019 at 10:15 AM EDT

Big Pharma Scares Off Short Sellers

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | May 2, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: American Water, Arconic, Cree, Dell, Humana, Merck, Qualcomm, Square, Tesla, Zynga and More

The top analyst upgrades, downgrades and initiations seen on Thursday included American Water Works, Arconic, Cree, Dell Technologies, Humana, Merck,…

Chris Lange | Apr 28, 2019 at 10:20 AM EDT

Apple, McDonald’s, Pfizer and More Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of Apple, Pfizer and other Dow companies scheduled to report their quarterly…

Chris Lange | Apr 26, 2019 at 8:45 AM EDT

Big Pharma Scares Off Short Sellers

The April 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Apr 24, 2019 at 7:10 AM EDT

15 Great Dividend Stocks Retirees Should Own in 2019

Here is a slate of 15 companies that most retirees likely would want to own in their portfolio now, including…

Chris Lange | Apr 10, 2019 at 9:40 AM EDT

Unbelievable Swings in Big Pharma Short Interest

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Mar 27, 2019 at 3:55 PM EDT

Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck

According to Credit Suisse, Pfizer investors might be getting to make up some of that relative underperformance of late.

1 … 16 17 18 19 20 … 73

Merck : MRK

All Merck Articles

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Top Analyst Upgrades and Downgrades: Barrick Gold, CannTrust, Foot Locker, Inogen, L3Harris, Merck, Petrobras, Starbucks, Symantec, Tesla and More

Short Sellers Seek Direction on Big Pharma

Our Top 10 Stock Moves & News Items for the Week

High Hopes and Expectations for Merck’s First Investor Day in Years

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

Top Analyst Upgrades and Downgrades: Alarm.com, Exxon, Goldman Sachs BDC, Merck, Pinterest, Shopify, Wendy’s, Zoom Video and More

Big Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: American Water, Arconic, Cree, Dell, Humana, Merck, Qualcomm, Square, Tesla, Zynga and More

Apple, McDonald’s, Pfizer and More Dow Stocks Reporting This Week

Big Pharma Scares Off Short Sellers

15 Great Dividend Stocks Retirees Should Own in 2019

Unbelievable Swings in Big Pharma Short Interest

Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America’s Debt Just Crossed a Level It Hasn’t Hit Since 1946, and Households Are Next in Line

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

Merck : MRK

All Merck Articles

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Top Analyst Upgrades and Downgrades: Barrick Gold, CannTrust, Foot Locker, Inogen, L3Harris, Merck, Petrobras, Starbucks, Symantec, Tesla and More

Short Sellers Seek Direction on Big Pharma

Our Top 10 Stock Moves & News Items for the Week

High Hopes and Expectations for Merck’s First Investor Day in Years

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

Top Analyst Upgrades and Downgrades: Alarm.com, Exxon, Goldman Sachs BDC, Merck, Pinterest, Shopify, Wendy’s, Zoom Video and More

Big Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: American Water, Arconic, Cree, Dell, Humana, Merck, Qualcomm, Square, Tesla, Zynga and More

Apple, McDonald’s, Pfizer and More Dow Stocks Reporting This Week

Big Pharma Scares Off Short Sellers

15 Great Dividend Stocks Retirees Should Own in 2019

Unbelievable Swings in Big Pharma Short Interest

Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America’s Debt Just Crossed a Level It Hasn’t Hit Since 1946, and Households Are Next in Line

Featured Reads

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line